You have 9 free searches left this month | for more free features.

Condition

Glioblastoma Multiforme (1)

Glioblastoma, Adult (1)

Overall Status

Completed (1)

Recruiting (1)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Apogenix GmbH (1)

University Hospital Heidelberg (1)

Collaborator

German Cancer Aid (1)

German Cancer Research Center (1)

National Center for Tumor Diseases, Heidelberg (1)

Intervention

apg101 (2)

alectinib (1)

atezolizumab (1)

blood drawing (1)

idasanutlin (1)

palbociclib (1)

temsirolimus (1)

vismodegib (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

apg101

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glioblastoma, Adult Trial in Germany (APG101, Alectinib, Idasanutlin)

Recruiting

Glioblastoma, Adult

APG101
+6 more

Berlin, Germany
+12 more

May 20, 2022

Glioblastoma Multiforme Trial in Austria, Germany (APG101, Blood drawing)

Completed

Glioblastoma Multiforme

APG101
Blood drawing

Graz, Austria
+20 more

Jun 15, 2015